Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CNMD | Common Stock | Options Exercise | $558K | +14K | +22222.22% | $39.87 | 14.1K | Nov 4, 2021 | Direct | |
transaction | CNMD | Common Stock | Sale | -$2.16M | -14K | -99.55% | $154.06 | 63 | Nov 4, 2021 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CNMD | Options To Purchase Common Stock | Options Exercise | $0 | -14K | -83.83% | $0.00 | 2.7K | Nov 4, 2021 | Common Stock | 14K | $39.87 | Direct | F2 |
Id | Content |
---|---|
F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $154.00 to $154.58. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
F2 | The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. |